SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-073987
Filing Date
2019-03-14
Accepted
2019-03-14 07:00:32
Documents
3
Period of Report
2019-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875560d8k.htm 8-K 15582
2 EX-99.1 d875560dex991.htm EX-99.1 76640
3 GRAPHIC g875560img2.jpg GRAPHIC 8826
  Complete submission text file 0001193125-19-073987.txt   105844
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 19679706
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10